{"id":"W1975501001","doi":"10.1002/art.10870","title":"Anakinra, a recombinant human interleukin‐1 receptor antagonist (r‐metHuIL‐1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo‐controlled trial","year":2003,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":true,"ca_institutions":"Saint Paul University","funders":"","keywords":"Anakinra; Medicine; Placebo; Adverse effect; Discontinuation; Rheumatoid arthritis; Internal medicine; Placebo-controlled study; Population; Disease; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002829688,0.001120942,0.001835426,0.0003479568,0.0004442336,0.0008484373,0.0006237874,0.001401911,0.003253813],"category_scores_gemma":[0.002484971,0.000364711,0.001213876,0.0004427658,0.0006605403,0.0006563397,0.0002279146,0.001586346,0.0005327087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003498176,"about_ca_system_score_gemma":0.0006397579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002650031,"about_ca_topic_score_gemma":0.0005818058,"domain_scores_codex":[0.9987041,0.0008347142,0.0001083357,0.000185514,0.000105044,0.00006237618],"domain_scores_gemma":[0.9987863,0.0004426226,0.0003860475,0.00006283521,0.00008539176,0.0002368822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9456445,0.005608996,0.002486501,0.002240985,0.002509982,0.0001119032,0.00007367713,0.0002487614,0.006885886,0.00007472199,0.001066681,0.03304745],"study_design_scores_gemma":[0.9500074,0.04271291,0.004533847,0.00007831243,0.000969991,0.00009294156,0.00002020448,0.0002242494,0.0005066876,0.00004864338,0.0007954802,0.000009281343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9630314,0.02962658,0.0008030072,0.000974292,0.0005637411,0.002294859,0.0007741624,0.0001242973,0.001807731],"genre_scores_gemma":[0.9844355,0.009490893,0.001074528,0.0008788338,0.0009577599,0.001640423,0.0006230717,0.00001521614,0.0008838402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003253813,"threshold_uncertainty_score":0.014965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008667948685326339,"score_gpt":0.2612080628427256,"score_spread":0.2525401141573992,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}